It has been a while since I have visited this board. I keep the entire community in my thoughts and am frequently praying for all effected by this disease.
My first primary was dx in 2006 - Breslow .31 level 4 - SNB neg. I just had my 5 year check up and was cleared for annual visits and told by my melanoma specialist the odds of this thing coming back are slim to none - Yippee! ....but wait, the next day I received a call from my derm who had removed a mole the week prior stating I have another melanoma. Derm wants me to go back to melanoma specialist and have the SNB even tho it appears it was caught early. This 2nd melanoma was a mole that was frozen off over a year and a half ago. Both docs on mutiple occasions said this is NOT cancer and not to worry. It started growing back pink - not the original brown color. It was then I insisted my derm remove it. I am very concerned that this mole was not removed and sent for biopsy in the first place and am concerned of the accuracy of the pathology report because of this. Anyone have this experience? Is it possible the mole was benign prior to it being burned off and then grew back malignant? Is it more likely my doc missed this and burned off a melanoma? Also, anyone have SNB with such thin lesions?
Below is the path report. Most I understand but a few points are confusing. Any help with interpretation is greatly appreciated.
The bulk of the process is confined to the epidermis and there is only a small focus of papillary dermis involvement in one or two areas. The thickness mesuresment seems to be largely accurate although it does extend focally to the base of the specimen. The lesion would be classified as Clarks level 2 as the paillary dermis is only focally involved in these sections. Breslows greater than .4mm - There is an asymmetrical melanocytic neoplasm with single malanocytes present diffusely thoughtout the epidermis with minimal melanin. There is focal involvement of the dermis. Less than one mitotic figuer per high power field was seen. Thereis a dense inflammatory infiltrate of lymphocytes as well.